Efg Asset Management (North America) Corp. Edgewise Therapeutics, Inc. Transaction History
Efg Asset Management (North America) Corp.
- $705 Million
- Q4 2024
A detailed history of Efg Asset Management (North America) Corp. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 41,338 shares of EWTX stock, worth $1.08 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
41,338Holding current value
$1.08 Million% of portfolio
0.16%Shares
1 transactions
Others Institutions Holding EWTX
# of Institutions
212Shares Held
101MCall Options Held
1.23MPut Options Held
416K-
Orbimed Advisors LLC San Diego, CA15MShares$391 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$232 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$160 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$157 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$130 Million10.85% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.64B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...